Lee; Francis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lee; Francis.The latest application filed is for "methods for reducing rewarding effects of morphine without affecting its analgesic effects".

Company Profile

5.9.19

Lee; Francis - New York NY
Lee; Francis - Jacksonville FL
Lee; Francis - Cambridge MA
Lee; Francis - Yardley PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Methods For Reducing Rewarding Effects Of Morphine Without Affecting Its Analgesic Effects App 20220288010 - Lee; Francis ; et al.	2022-09-15
Collaborative and dynamic mobile workflow execution platform Grant 11,442,772 - Lee September 13, 2	2022-09-13
Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates Grant 11,436,246 - Lee , et al. September 6, 2	2022-09-06
Generating anti-infective design spaces for selecting drug candidates Grant 11,424,008 - Lee , et al. August 23, 2	2022-08-23
Generating enhanced graphical user interfaces for presentation of anti-infective design spaces for selecting drug candidates Grant 11,403,316 - Lee , et al. August 2, 2	2022-08-02
Carbamate and urea compounds as multikinase inhibitors Grant 11,358,949 - Wu , et al. June 14, 2	2022-06-14
Generating Enhanced Graphical User Interfaces For Presentation Of Anti-infective Design Spaces For Selecting Drug Candidates App 20220164343 - Lee; Francis ; et al.	2022-05-26
Generating Anti-infective Design Spaces For Selecting Drug Candidates App 20220165359 - Lee; Francis ; et al.	2022-05-26
Generating Enhanced Graphical User Interfaces For Presentation Of Anti-infective Design Spaces For Selecting Drug Candidates App 20220164342 - Lee; Francis ; et al.	2022-05-26
Generating Anti-infective Design Spaces For Selecting Drug Candidates App 20220165360 - Lee; Francis ; et al.	2022-05-26
Heterocyclic Compounds As Prmt5 Inhibitors App 20220089612 - Wu; Wen-Lian ; et al.	2022-03-24
Artificial Intelligence Engine For Generating Candidate Drugs Using Experimental Validation And Peptide Drug Optimization App 20220059196 - Lee; Francis ; et al.	2022-02-24
Collaborative and Dynamic Mobile Workflow Execution Platform App 20210365284 - Lee; Francis	2021-11-25
Artificial Intelligence Engine Architecture For Generating Candidate Drugs App 20210366581 - Lee; Francis ; et al.	2021-11-25
Cyclic compounds as immunomodulating agents Grant 11,180,497 - Wu , et al. November 23, 2	2021-11-23
Artificial Intelligence Engine Architecture For Generating Candidate Drugs App 20210304854 - Lee; Francis ; et al.	2021-09-30
Artificial Intelligence Engine Architecture For Generating Candidate Drugs App 20210295955 - Lee; Francis ; et al.	2021-09-23
Macrocyclic compounds as TRK kinase inhibitors and uses thereof Grant 11,098,046 - Wu , et al. August 24, 2	2021-08-24
Artificial Intelligence Engine For Generating Candidate Drugs App 20210249108 - LEE; Francis ; et al.	2021-08-12
Artificial intelligence engine architecture for generating candidate drugs Grant 11,049,590 - Lee , et al. June 29, 2	2021-06-29
Carbamate And Urea Compounds As Multikinase Inhibitors App 20210163445 - Wu; Wen-Lian ; et al.	2021-06-03
Macrocyclic Compounds As Trk Kinase Inhibitors And Uses Thereof App 20200385386 - Wu; Wen-Lian ; et al.	2020-12-10
Heterocyclic Compounds As Prmt5 Inhibitors App 20200369667 - Wu; Wen-Lian ; et al.	2020-11-26
Cyclic Compounds As Immunomodulating Agents App 20200239464 - Wu; Wen-Lian ; et al.	2020-07-30
Collaborative and dynamic mobile workflow execution platform App 20190213518 - Lee; Francis ; et al.	2019-07-11

Company Registrations

SEC	0001357598	Lee Francis
SEC	0001251833	LEE FRANCIS

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.